Replies to post #192670 on Biotech Values

[DewDiligence]

MNTA’s PR on favorable CAFC ruling:

http://finance.yahoo.com/news/momenta-pharmaceuticals-announces-cafc-decision-143714364.html

An immediate launch of Glatopa (generic Copaxone) should now follow, although the PR doesn’t actually announce the launch.

[vinmantoo]

{{NVS/MNTA are now free to lunch Glatopa (generic Copaxone)}}

I think they should order lobster and some fine champagne to wash it down with! ;)

[zipjet]

Is Glatopa substitutable?

How big is the remaining market at the 20mg dose?

[DewDiligence]

NVS/MNTA launch Glatopa (generic 20mg Copaxone):

http://finance.yahoo.com/news/momenta-pharmaceuticals-announces-launch-glatopa-210000503.html

MNTA gets an immediate $10M milestone payment from NVS and is eligible to receive up to $120M in anniversary-based and sales-based milestones.